Tata Elxsi Limited (500408) Earnings Call Transcripts

Tata Elxsi Limited's Latest Earnings Call - Q4 FY2026

In Q4 FY '25-'26, Tata Elxsi Limited reported revenues of INR 993.8 crores, reflecting a 0.9% quarter-on-quarter growth in constant currency. The company faced challenges in its Healthcare and Life Sciences vertical, which saw a 13.1% decline, attributed to delays in deal awards. Management has lowered its growth expectations for FY '27 to high single digits, down from previous double-digit aspirations, signaling potential headwinds in revenue generation and client decision-making processes.

Reported metrics

Guidance from management

Management has lowered FY '27 revenue growth expectations to high single digits, citing geopolitical uncertainties and client decision-making delays as factors impacting growth.

What management said

It depends on business to business, I would say. Usually, yes, even if you win a deal for it to make a significant impact it takes anywhere between 9 months, 12 months, right, for ramp-up, actually, ramp-ups to happen and start delivering.

It's both, right? Definitely, we are using a lot of that for internal efficiencies however, there are customers that are demanding better efficiencies, productivity and so on, which automatically leads to if you're able to deliver that performance and productivity, then a better pricing power, right? So it's a combination of both.

What analysts pressed on

Analysts expressed concerns regarding the significant decline in the healthcare vertical and the potential impact of delayed deal closures on future revenue growth. There were also questions about the sustainability of margin improvements given current utilization rates.

Main topics on the call

• Revenue Performance — Tata Elxsi reported revenues of INR 993.8 crores for Q4 FY '25-'26, growing 0.9% quarter-on-quarter in constant currency. Management stated, 'we are delighted with 2 strategic wins' which they believe will pave the way f...
• Healthcare Vertical Decline — The Healthcare and Life Sciences vertical experienced a significant decline of 13.1% quarter-on-quarter due to 'delays in deal awards.' Management expressed optimism about recovering in Q1 FY '27 but acknowledged the imp...
• Media and Communication Growth — The Media and Communication segment achieved a 5.6% quarter-on-quarter revenue growth, driven by deal ramp-ups and a large multiyear deal. Management noted, 'we are still challenged' but expressed confidence in sustainin...
• Margin Improvement — EBITDA margin improved to 24.6%, up 130 basis points sequentially, attributed to operational efficiencies and fixed-price contracts. Management highlighted that 'every 1% increase in utilization also helps at least 25 to...

Read the full Tata Elxsi Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 30 Tata Elxsi Limited earnings call transcripts on record, spanning January 14, 2020 to July 14, 2026. Based on this history, Tata Elxsi Limited reports quarterly. The most recent call on file is dated July 14, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

500408

Exchange

BSE

Country

IN

Sector

Information Technology

Industry

Software

Calls on record

30

First call

January 14, 2020

Most recent

July 14, 2026

Reporting cadence

quarterly